These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2094722)

  • 1. Insulin degradation in vivo: a high-performance liquid chromatographic analysis.
    Benzi L; Cecchetti P; Ciccarone AM; Di Cianni G; Iozzi LC; Caricato F; Navalesi R
    J Chromatogr; 1990 Dec; 534():37-46. PubMed ID: 2094722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of degraded A14-125I-insulin in human fibroblasts by the use of high performance liquid chromatography.
    Stentz FB; Harris HL; Kitabchi AE
    Diabetes; 1983 May; 32(5):474-7. PubMed ID: 6341131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin degradation into monocytes from normal subjects: a high performance liquid chromatographic analysis.
    Benzi L; Marchetti P; Brunetti A; Ciccarone AM; Cecchetti P; Trischitta E; Di Cianni G; Squatrito S; Navalesi R
    J Endocrinol Invest; 1988 Apr; 11(4):303-7. PubMed ID: 3045192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity.
    Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R
    J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High performance liquid chromatographic analysis of insulin degradation by rat skeletal muscle insulin protease.
    Hamel FG; Peavy DE; Ryan MP; Duckworth WC
    Endocrinology; 1986 Jan; 118(1):328-33. PubMed ID: 3510119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies.
    Clot JP; Janicot M; Fouque F; Desbuquois B; Haumont PY; Lederer F
    Mol Cell Endocrinol; 1990 Sep; 72(3):175-85. PubMed ID: 2289630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood.
    Benzi L; Cecchetti P; Ciccarone A; Pilo A; Di Cianni G; Navalesi R
    Diabetes; 1994 Feb; 43(2):297-304. PubMed ID: 8288054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
    Ryan MP; Peavy DE; Frank BH; Duckworth WC
    Endocrinology; 1984 Aug; 115(2):591-9. PubMed ID: 6378594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of HPLC in disposition study of A14-125I-labeled insulin in mice.
    Sato H; Tsuji A; Hirai K; Kang YS
    Diabetes; 1990 May; 39(5):563-9. PubMed ID: 2185107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labeling of insulin with non-radioactive 127I and application to incorporation of radioactive 125I for use in receptor-binding experiments by high-performance liquid chromatography.
    Rissler K; Engelmann P
    J Chromatogr B Biomed Appl; 1996 Apr; 679(1-2):21-9. PubMed ID: 8998565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-mediated endocytosis of A14-125I-insulin by the nonfiltering perfused rat kidney.
    Sato H; Yoshioka K; Terasaki T; Tsuji A
    Biochim Biophys Acta; 1991 Apr; 1073(3):442-50. PubMed ID: 2015267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin degradation products from perfused rat kidney.
    Duckworth WC; Hamel FG; Liepnieks J; Peavy D; Frank B; Rabkin R
    Am J Physiol; 1989 Feb; 256(2 Pt 1):E208-14. PubMed ID: 2645781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid means of separating A14-125I-insulin from heterogeneously labeled insulin molecules for biologic studies.
    Stentz FB; Wright RK; Kitabchi AE
    Diabetes; 1982 Dec; 31(12):1128-31. PubMed ID: 6757025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of biological variant insulin molecules from different species by reversed-phase high-performance liquid chromatography (HPLC).
    Kalant D; Crawhall JC; Posner BI
    Biochem Med; 1985 Oct; 34(2):230-40. PubMed ID: 3910033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endosome-lysosome transfer of insulin and glucagon in a liver cell-free system.
    Chauvet G; Tahiri K; Authier F; Desbuquois B
    Eur J Biochem; 1998 Jun; 254(3):527-37. PubMed ID: 9688263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of injected glucagon taken up by rat liver in vivo. Degradation of internalized ligand in the endosomal compartment.
    Authier F; Janicot M; Lederer F; Desbuquois B
    Biochem J; 1990 Dec; 272(3):703-12. PubMed ID: 2268296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of insulin-degrading activity of intact and subcellular components of human fibroblasts.
    Stentz FB; Harris HL; Kitabchi AE
    Endocrinology; 1985 Mar; 116(3):926-34. PubMed ID: 3882399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High performance liquid chromatographic analysis of insulin degradation products from a cultured kidney cell line.
    Duckworth WC; Hamel FG; Liepnieks J; Frank BH; Yagil C; Rabkin R
    Endocrinology; 1988 Dec; 123(6):2701-8. PubMed ID: 3058457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin binding to cultured adult hepatocytes. Effects of bacitracin and chloroquine on the nature of cell-associated radioactivity.
    Fleig WE; Hoss G; Nöther-Fleig G; Ditschuneit H
    Biochem J; 1986 Jul; 237(1):99-104. PubMed ID: 3541897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversed-phase high-performance liquid chromatographic characterization of acetic acid extracts of the normal and the diabetic human pancreas.
    Welinder BS; Linde S
    J Chromatogr; 1991 Jan; 537(1-2):201-17. PubMed ID: 2050780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.